Pred-hERG 4.2 was used to make predictions on hERG inhibition, which is known to precipitate cardiac arrhythmias and significantly contribute to late pre-clinical and clinical stage failure of drugs [20,21]. The gene discussed is KCNH2; the disease is cardiac arrhythmia.